CIBBIM – Nanomedicine. Bioengineering, Cell Therapy and Surgery in Congenital Malformations : VHIR Annual Report 2020

Obstetrics, Pediatrics and Genetics

< Back

Overview

The Obstetrics, Pediatrics and Genetics area is focused on the research on the congenital malformations and pediatric diseases. The Fetal Maternal Medicine group creates synergies through the combined work of basic science researchers and clinical investigators in the preclinical basis of placental insufficiency complications and congenital heart disease. The Bio-Cell Fetal group, recently incorporated, studies basic pathophysiological mechanisms of fetal and pediatric congenital malformations, while the Growth and Development group does research on pediatric endocrine diseases. There is also a Genetics Medicine group that combines genetic diagnosis and research and is pioneer in Spain.

Publications

95
total
406
impact factor
4.28
average impact factor

Group Leader: Manuel López Paredes

The Bioengineering, Cell Therapy and Congenital Malformation Surgery research group is made up of clinical researchers (pediatric surgeons, neonatologists and obstetricians) and basic researchers (biochemists, biotechnologists and biologists), which makes up a large multidisciplinary team with extensive experience in biomedical and clinical research. The objectives of the different lines of research carried out are the study of human congenital malformations, the development of new therapies based on advanced surgical techniques, as well as cell and pharmacological therapy to promote tissue regeneration for therapeutic purposes. During 2020, our team has published 27 scientific articles and has obtained competitive funding of excellence at the national (CDTI) and international (H2020) levels for the study of innovative therapies in osteoarticular pathology and regenerative medicine.

VHIR Annual Report 2020